Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

1gene

1gene
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$8.06M LATEST DEAL AMOUNT
2 INVESTORS
Description

Provider of gene testing services intended to serve the biotechnological sector in China. The company's services include health risk detection testing, tumor gene detection and tumor precision motoring, enabling physicians to get accurate results and treat their patients in an enhanced way.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Primary Office
  • 15th Floor, Yuanfang Technology Center
  • 88 Jucai Road, Binjiang District
  • Hangzhou, Zhejiang
  • China

+86 0571 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore 1gene’s full profile, request a free trial.

1gene Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Corporate (Series A) 24-Jun-2015 $8.06M 00.000 000.00 Completed Generating Revenue
1. Seed Round 21-Oct-2014 00000 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

1gene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Hangzhou Everfine Photo-e-info Company Corporation Minority 000 0000 000000 0
Tisiwi Venture Capital Minority 000 0000 000000 0

1gene Executive Team (1)

Name Title Board
Seat
Contact
Info
Junyi Wang President, Founder, Chairman, General Manager & Chief Executive Officer